Diagnostic importance of S100A9 and S100A12 in breast cancer
BIOMEDICINE & PHARMACOTHERAPY, vol.76, pp.52-56, 2015 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 76
- Publication Date: 2015
- Doi Number: 10.1016/j.biopha.2015.10.029
- Journal Name: BIOMEDICINE & PHARMACOTHERAPY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.52-56
- Keywords: Breast cancer, S100A9, S100A12, Inflammation, Target marker, HEPATOCELLULAR-CARCINOMA, TUMOR DIFFERENTIATION, PROTEINS S100A8, EXPRESSION, ADENOCARCINOMA, TISSUE, ROLES, IDENTIFICATION, INFLAMMATION, METASTASIS
- Istanbul University Affiliated: No
Abstract
Background: The most frequent cause of cancer deaths throughout the world is breast cancer (BC). Therefore, preventing, diagnosing and treating BC has gained importance. S100 protein probably plays an important role in carcinogenesis, cancer development, and metastasis. In this study, we aimed at diagnostic and clinic-pathological importance of serum levels of S100A9 and S100A12 with known cytokine-like pro-inflammatory effects in BC.